Hospitals reported to the Ministry of Health about three Israelis who were hospitalized with a serious eye infection and fear of severe vision damage after using the drug “Eylea”. After an inspection conducted by the Ministry of Health, it was found that the three cases occurred at different times. The office checks whether the source of the contamination is the drug or the injection process.

Eylea is intended for the treatment of visual impairment caused by the following retinal diseases: macular edema due to diabetes, age-related macular degeneration, pathological blood vessel growth in the retina and macular edema following a blockage in the central retinal vein or section of the retinal vein.

Leave a Reply

Your email address will not be published. Required fields are marked *